Zydus Therapeutics
Zydus Therapeutics is seeking a Director, Patient Marketing to drive the patient commercial strategy for its lead drug candidate, saroglitazar, as it advances toward a potential launch for Primary Biliary Cholangitis. This role involves leading US patient marketing initiatives, translating brand strategy into cross-channel patient education and community engagement, and ensuring launch readiness. The position requires collaboration with cross-functional teams to manage agency partners, patient advocacy groups, and materials through regulatory review.
Headquarters
Pennington, New Jersey, United States
Zydus Therapeutics is a clinical-stage, specialty-focused biopharmaceutical company dedicated to developing transformative treatments for rare and serious liver diseases. As a subsidiary of Zydus Lifesciences, the company leverages a research team of 1,300 scientists and is currently enrolling patients in two late-stage clinical trials, including studies on Primary Biliary Cholangitis (PBC) and NASH. Its pipeline includes Saroglitazar Mg, which has received FDA Fast Track Designation for PBC treatment.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Zydus Therapeutics.
Zydus Therapeutics didn’t post a salary, so this is our estimate from similar listings.
16% below the average for this role
Marketing Lead, PBC
Ipsen
Associate Director U.S., Patient Marketing Admilparant
Bristol Myers Squibb
Director, Patient Advocacy
Alfasigma
Associate Director of Gastroenterology Consumer Marketing
Regeneron Pharmaceuticals
Senior Director, US HCP Marketing and Omnichannel, Obesity and Related
lifelancer
VP of Marketing
Lumo Health